Neil Woodford's £736m Patient Capital trust saw a much-needed pick-up in performance in 2018 as a number of its success stories, many of which are unlisted companies, are "gradually beginning to account for a larger portion of assets".
In its final results for the 12 months to 31 December, released this morning, the board revealed many of the trust's unquoted holdings - which represent 65% of the portfolio - saw significant progression...
Partner Insight: In this environment, a well-resourced credit research team is essential and having traders to keep check on markets is very helpful too, according to Fidelity fixed income managers Sajiv Vaid, Peter Khan and Kris Atkinson
Impact of political turmoil and Brexit
Latest Incisive Works research
In recent weeks, investors have fixated on the inversion of several sovereign yield curves, most notably the US Treasury curve.
How are VCTs and EIS products doing?